艾塞那肽与急性胰腺炎

Exenatide and acute pancreatitis.

作者信息

Tripathy N R, Basha S, Jain R, Shetty S, Ramachandran A

机构信息

Dr. A. Ramachandran's Diabetes Hospitals, Chennai 600 008, India.

出版信息

J Assoc Physicians India. 2008 Dec;56:987-8.

PMID:19322980

Abstract

For a female, type 2 diabetic patient, with 4 years duration of diabetes, Exenatide (Byetta) was prescribed as glycaemic control was not satisfactory along with Glimepiride and Metformin. She had gastrointestinal disturbances, since the first day of the injection. From the eighth day she developed signs of acute pancreatitis which was confirmed with CT-Scan and biochemical investigations. Byetta was withdrawn, the patient was treated for acute pancreatitis and the symptoms subsided.

摘要

对于一位患有2型糖尿病4年的女性患者，由于使用格列美脲和二甲双胍时血糖控制不佳，遂开具了艾塞那肽（百泌达）。自注射第一天起，她就出现了胃肠道不适。从第八天开始，她出现了急性胰腺炎的症状，经CT扫描和生化检查得以确诊。停用了百泌达，该患者接受了急性胰腺炎治疗，症状逐渐消退。